Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirena Extended Use Study
NCT02985541Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2016
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levonorgestrel intrauterine system in contraception and Heavy menstrual bleeding, sponsored by Bayer. Primary endpoint: Number of Pregnancies Per 100 Women Years (Pearl Index). Started Dec 2016; status: completed.
02
Drugs
levonorgestrel intrauterine system
03
Conditions
contraceptionHeavy menstrual bleeding
Beyond the preview
Go deeper on NCT02985541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985541.